Basta Paweł, Jach Robert, Laskowicz Lukasz, Kotlarz Agnieszka, Schwarz Janina
Ginekol Pol. 2015 Aug;86(8):590-7. doi: 10.17772/gp/58986.
In the mid-80's and 90's of the last century uterine-sparing surgical treatment methods were proposed to women wishing to preserve their fertility.
The aim of the study was to assess practical application of conization or radical vaginal trachelectomy with laparoscopic lymphadenectomy in women with squamous cell cervical cancer (FIGO stages IA and IB1) who want to retain their ability to procreate. Material and methods: A total of 119 women (aged 25-43 years) were included in the study Ninety-six women (60 - IA1 and 36 - IA2) were deemed eligible for conization and 23 women with stages IA2 and IB1 with neoplastic changes of <2cm in diameter were qualified for radical vaginal trachelectomy with laparoscopic lymphadenectomy
Conization was not radical in 9 cases and these women were reoperated. A 5-year follow-up in patients after conization revealed disease recurrence (CIN) in 3 IA1 cases (6.5%), and 2 IA2 cases (9.1%). In patients with follow-up of <5 years, no recurrence was observed in 9 out of 10 A1 cases. Similarly there was no recurrence in 7 out of 9 lA2 cases. A 5-year follow-up in patients after trachelectomy confirmed disease recurrence (CIN) in 1 IA2 case (6.25%). There was no disease recurrence in 2 IA1 cases and 4 IB1 cases. Out of 8 subjects staged 1A2 with a follow-up of <5 years, no disease recurrence was observed in 7 (87.5%) patients. During the same follow-up time, no disease recurrence was detected in 3 patients staged IB1.
Proper uterine-sparing treatment with appropriate qualification guarantees adequate control of the treatment process in women with cervical cancer stages IA and IB1 (<2 cm in diameter) according to FIGO.
在上世纪80年代中期至90年代,针对希望保留生育能力的女性,提出了保留子宫的手术治疗方法。
本研究的目的是评估锥切术或根治性阴道宫颈切除术联合腹腔镜淋巴结清扫术在希望保留生育能力的鳞状细胞宫颈癌(国际妇产科联盟(FIGO)分期IA和IB1期)女性中的实际应用。材料与方法:共有119名女性(年龄25 - 43岁)纳入研究。96名女性(60名IA1期和36名IA2期)被认为适合锥切术,23名IA2期和IB1期且肿瘤直径<2cm的女性符合根治性阴道宫颈切除术联合腹腔镜淋巴结清扫术的条件。
9例锥切术未达到根治效果,这些女性接受了再次手术。锥切术后患者5年随访显示,3例IA1期病例(6.5%)和2例IA2期病例(9.1%)出现疾病复发(CIN)。在随访时间<5年的患者中,10例A1期病例中有9例未观察到复发。同样,9例IA2期病例中有7例未复发。宫颈切除术后患者5年随访证实1例IA2期病例(6.25%)出现疾病复发(CIN)。2例IA1期病例和4例IB1期病例未出现疾病复发。在8例随访时间<5年的IA2期受试者中,7例(87.5%)患者未观察到疾病复发。在相同的随访时间内,3例IB1期患者未检测到疾病复发。
根据FIGO标准,对IA期和IB1期(直径<2cm)宫颈癌女性进行适当的保留子宫治疗并给予适当的资格认定,可确保对治疗过程进行充分控制。